跳转至内容
Merck
CN
  • Synthesis and aminoacyl-tRNA synthetase inhibitory activity of aspartyl adenylate analogs.

Synthesis and aminoacyl-tRNA synthetase inhibitory activity of aspartyl adenylate analogs.

Bioorganic & medicinal chemistry (2004-12-08)
Stéphane Bernier, Pierre-Marie Akochy, Jacques Lapointe, Robert Chênevert
摘要

Three nonhydrolyzable aspartyl adenylate analogs have been prepared and tested as inhibitors of E. coli aspartyl-tRNA synthetase. 5'-O-[N-(L-Aspartyl)sulfamoyl]adenosine is a potent competitive inhibitor (K(i) = 15 nM) whereas L-aspartol adenylate is a weaker inhibitor (K(i) = 45 microM) with respect to aspartic acid. The corresponding ketomethylphosphonate (a novel isosteric replacement) is also a strong inhibitor (K(i) = 123 nM).